Position in TEVA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,231,220
+$1,204,272 QoQ
Shares Held
331,500
-0.4% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#144
of 671 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $37,173,300 across 16 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (30.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
331,500 | $11,231,220 | |
| 2 | PRGO |
PERRIGO Co plc
|
874,359 | $9,084,590 | |
| 3 | ZTS |
Zoetis Inc.
|
69,200 | $4,972,712 | |
| 4 | VTRS |
Viatris Inc
|
203,200 | $3,226,816 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
125,000 | $3,076,250 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
24,000 | $2,662,560 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
23,000 | $1,069,730 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
13,860 | $568,675 |
All Filings in TEVA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,231,220 | 331,500 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $10,026,948 | 332,900 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $11,129,486 | 356,600 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $8,921,835 | 441,675 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,399,121 | 441,475 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,687,102 | 435,075 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,099,700 | 367,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,324,690 | 184,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $812,500 | 50,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $451,520 | 32,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $334,080 | 32,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $326,400 | 32,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $310,236 | 41,200 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $373,470 | 42,200 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $392,160 | 43,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $435,780 | 54,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $428,640 | 57,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $554,010 | 59,000 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $472,590 | 59,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $613,620 | 63,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $683,298 | 69,020 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $831,110 | 72,020 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||